Login

Ask AI

$SNWV

$5.13 +$0.06 (1.18%) Close

$SNWV Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$SNWV Management Team

Mr. Peter Sorensen

Chief Financial Officer

Age 32

Compensation -

Sex Male

Mr. Timothy Wern

Executive Vice President - Sales

U.S. Wound Business

Age 57

Compensation -

Sex Male

Mr. Daniel Coyle

Chief Operating Officer

Age 35

Compensation -

Sex Male

Mr. Morgan Frank

Chairman of the Board

Chief Executive Officer

Age 53

Compensation $1.384M USD

Sex Male

Dr. Iulian Cioanta

Chief Science and Technology Officer

Age 62

Compensation $378.1K USD

Sex Male

Mr. Peter Stegagno

Chief Regulatory Officer

Age 65

Compensation $247.8K USD

Sex Male

Name / Title	Age	Compensation	Sex	Social Media
Mr. Peter Sorensen Chief Financial Officer	32	-	Male
Mr. Timothy Wern Executive Vice President - Sales U.S. Wound Business	57	-	Male
Mr. Daniel Coyle Chief Operating Officer	35	-	Male
Mr. Morgan Frank Chairman of the Board Chief Executive Officer	53	$1.384M USD	Male
Dr. Iulian Cioanta Chief Science and Technology Officer	62	$378.1K USD	Male
Mr. Peter Stegagno Chief Regulatory Officer	65	$247.8K USD	Male

Board of Directors

From the proxy statement filed Apr 29, 2026

Directors

5

serving now

Independent

Not stated

the proxy does not say

Average tenure

3.6 years

from year joined

CEO also chairs the board

Yes

Morgan Frank

Director	Age	On board	Independent	Committees	Other public boards	Pay	Source
Morgan Frank Board chair, CEO	54	2022 4 years	Not stated	None stated	Modular Medical, Inc. (MODD)	Paid as CEO
Gregory Bazar	50	2025 1 year	Not stated	None stated	None stated	Not stated
Jeffrey Blizard	57	2022 4 years	Not stated	None stated	None stated	Not stated
Ian Miller Lead independent director	50	2022 4 years	Not stated	None stated	None stated	Not stated
James Tyler	69	2021 5 years	Not stated	None stated	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

14 disclosed in the proxy filed Apr 29, 2026

James Besser

$400,000

2022

Purchased Notes accompanied by Warrants in August and November 2022 private placements

With the Company Open in proxy

Morgan C. Frank

Chairman of the Board and Chief Executive Officer

$250,000

2022

Purchased Notes accompanied by Warrants in August and November 2022 private placements

With the Company Open in proxy

Kevin A. Richardson, II

former Chairman of the Board and former Chief Executive Officer and Chief Strategy Officer

$261,780

2022

Purchased Notes accompanied by Warrants in August and November 2022 private placements

With the Company Open in proxy

A. Michael Stolarski

former director

$1,434,966

2022

Purchased Notes accompanied by Warrants in August and November 2022 private placements

With the Company Open in proxy

Manchester Explorer, L.P.

beneficial owner of more than five percent of the Company's common stock

$2,500,000

2022

Purchased Notes accompanied by Warrants in August and November 2022 private placements

With the Company Open in proxy

Opaleye, L.P.

beneficial owner of more than five percent of the Company's common stock

$2,900,000

2022

Purchased Notes accompanied by Warrants in August and November 2022 private placements

With the Company Open in proxy

Certain other directors

directors of the Company

$527,000

2022

Received Notes for accrued and unpaid director fees

With the Company Open in proxy

Manchester Explorer, L.P.

$300,000

May 2023

Purchased Notes accompanied by Warrants in May 2023

With the Company Open in proxy

Manchester Explorer, L.P.

$100,000

December 2023

Purchased Notes accompanied by Warrants in December 2023

With the Company Open in proxy

A. Michael Stolarski

$149,993

July 2023

Purchased ABS Promissory Notes issued in July 2023

With the Company Open in proxy

Manchester Explorer, L.P.

$862,457

July 2023

Purchased ABS Promissory Notes issued in July 2023

With the Company Open in proxy

Opaleye, L.P.

$299,985

July 2023

Purchased ABS Promissory Notes issued in July 2023

With the Company Open in proxy

Manchester Explorer, L.P.

beneficial owner of more than five percent of the Company's common stock

$0.5 million

2024

Promissory note bearing 15% interest, paid in full in October 2024

With the Company Open in proxy

Manchester Explorer, L.P.

beneficial owner of more than five percent of the Company's common stock

$1,500,000

Purchased common stock in the October 2024 Private Placement

With the Company Open in proxy

Loading...

Comments